BioLineRx (BLRX) Tops Q1 EPS by 13c

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• RBC bullish on Kraft Heinz, sees return to growth in 2027
• Faraday Future says it regained Nasdaq compliance after equity shortfall
• Oscar Health Inc (OSCR) PT Raised to $48 at Piper Sandler